List of Studies ( Metabolite:PC P-36:2 or PC O-36:3)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004333 | AN007236 | Oxidative pentose phosphate pathway is required for T cell activation and anti-tumor immunity - G6PD-knockout | T-cells | Mouse | Cancer | Princeton University | LC-MS |
| ST004132 | AN006847 | Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. | Blood | Mouse | Diabetes | Broad Institute of MIT and Harvard | LC-MS |
| ST004132 | AN006847 | Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. | Cecal content | Mouse | Diabetes | Broad Institute of MIT and Harvard | LC-MS |
| ST004093 | AN006783 | Autoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation | T-cells | Mouse | Autoimmune disease | Broad Institute of MIT and Harvard | LC-MS |
| ST004093 | AN006784 | Autoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation | T-cells | Mouse | Autoimmune disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003805 | AN006254 | Epigenetic changes, neuronal dysregulation and behavioral abnormalities in Zmym2+/- mutant mice, a genetic animal model of schizophrenia and neurodevelopmental disorders | Brain | Mouse | Neurodevelopment Disorder | Broad Institute of MIT and Harvard | LC-MS |
| ST003805 | AN006254 | Epigenetic changes, neuronal dysregulation and behavioral abnormalities in Zmym2+/- mutant mice, a genetic animal model of schizophrenia and neurodevelopmental disorders | Brain | Mouse | Schizophrenia | Broad Institute of MIT and Harvard | LC-MS |
| ST003788 | AN006444 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Meningitis | Broad Institute of MIT and Harvard | LC-MS |
| ST003788 | AN006444 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Tuberculosis | Broad Institute of MIT and Harvard | LC-MS |
| ST003514 | AN005769 | Highly reliable LC-MS lipidomics database for efficient human plasma profiling based on NIST SRM 1950 | Blood | Human | Universidad CEU San Pablo | LC-MS | |
| ST003438 | AN005649 | Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease | Fly Head | Fruit fly | Parkinsons disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003438 | AN005650 | Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease | Fly Head | Fruit fly | Parkinsons disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST002903 | AN004764 | Identification and targeting of microbial putrescine acetylation in bloodstream infections | Blood | Human | Septic shock | Broad Institute of MIT and Harvard | LC-MS |
| ST002817 | AN004585 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Heart | Mouse | Cardiomyopathy | University of California, San Francisco | LC-MS |
| ST002764 | AN004498 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002764 | AN004499 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002700 | AN004376 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002700 | AN004377 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002536 | AN004173 | Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma | Thyroid | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST002471 | AN004034 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Feces | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002470 | AN004030 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling | Blood | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002400 | AN003909 | Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis | Cultured cells | Human | INSERM | LC-MS | |
| ST002246 | AN003667 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002023 | AN003293 | A targeted metabolomics study for assessing rodent thyroid toxicity | Liver | Rat | Thyroid toxicity | Helmholtz Centre for Environmental Research | LC-MS |
| ST002023 | AN003293 | A targeted metabolomics study for assessing rodent thyroid toxicity | Thyroid | Rat | Thyroid toxicity | Helmholtz Centre for Environmental Research | LC-MS |
| ST002002 | AN003265 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001942 | AN003185 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | LC-MS |
| ST001919 | AN003118 | Exposure to environmental contaminants is associated with alterations in hepatic lipid metabolism in non-alcoholic fatty liver disease | Liver | Mouse | Fatty liver disease | Örebro University | LC-MS |
| ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001888 | AN003060 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001836 | AN002978 | Quantitative lipids study on blood serum and ceacal content of rat models | Blood | Rat | Helmholtz Centre for Environmental Research | LC-MS | |
| ST001836 | AN002978 | Quantitative lipids study on blood serum and ceacal content of rat models | Cecum | Rat | Helmholtz Centre for Environmental Research | LC-MS | |
| ST001815 | AN002946 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001815 | AN002947 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001637 | AN002678 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001521 | AN002534 | Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) | Blood | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001396 | AN002335 | Quantitative Lipids study on total murine liver tissue from mice at different age | Liver | Mouse | Helmholtz Centre for Environmental Research | LC-MS | |
| ST001289 | AN002142 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST001288 | AN002141 | Subcellular organelle lipidomics in TLR-4-activated macrophages | Macrophages | Mouse | LIPID MAPS | LC-MS | |
| ST001211 | AN002018 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001211 | AN002019 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001151 | AN001899 | 4-day dietary effect of fast food vs Mediterranean diet to HDL lipidome | Blood | Human | University of California, Davis | LC-MS | |
| ST001113 | AN001809 | Exposure to Oral Contraceptives Alters Human Endometrial Stem Cells Culture Media Metabolomics | Stem cells | Human | Universidade Federal de Sao Paulo | MS(Dir. Inf.) | |
| ST001102 | AN001791 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-II) | Whole animals | Dungeness crab | NOAA NWFSC | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001000 | AN001881 | Gut microbiome structure and metabolic activity in inflammatory bowel disease | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | LC-MS | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | LC-MS | |
| ST000987 | AN001613 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | Blood | Human | University of California, Davis | LC-MS | |
| ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | LC-MS | |
| ST000985 | AN001611 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | Blood | Human | University of California, Davis | LC-MS | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | LC-MS | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | LC-MS | |
| ST000923 | AN001516 | Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease | Feces | Human | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST000880 | AN001436 | Diet, genetics and gut microbiome drive dynamic changes in plasma metabolites [cecal] | Blood | Mouse | Broad Institute of MIT and Harvard | LC-MS | |
| ST000550 | AN000840 | Metabolomics marker of brown adipose tissue in men | Adipose tissue | Human | Leiden University Medical Center | LC-MS | |
| ST000331 | AN000529 | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | Prostate | Mouse | University of California, Davis | LC-MS | |
| ST000331 | AN000530 | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | Prostate | Mouse | University of California, Davis | LC-MS | |
| ST000330 | AN000527 | Effects of Zinc on GI tract metabolites | Esophagus | Mouse | University of California, Davis | LC-MS | |
| ST000329 | AN000525 | Minimal change disease and focal segmental sclerosis in urine | Urine | Human | Kidney disease | University of California, Davis | LC-MS |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Colon | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Duodenum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Ileum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Rectum | Dog | University of California, Davis | LC-MS | |
| ST000324 | AN000516 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 3:Ovaries) | Follicular fluid | Cow | University of California, Davis | LC-MS | |
| ST000321 | AN000510 | Effects of LGG on current drinkers gut metabolism | Feces | Mouse | Alcoholism | University of California, Davis | LC-MS |
| ST000089 | AN000141 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis | Ovarian cancer cells | Human | Cancer | University of California, Davis | LC-MS |
| ST000089 | AN000142 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis | Ovarian cancer cells | Human | Cancer | University of California, Davis | LC-MS |
| ST000082 | AN000133 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of serum samples | Blood | Human | Cancer | University of California, Davis | LC-MS |
| ST000077 | AN000123 | Metabolite changes associated with methionine stress sensitivity of cancer (CSH QTOF MS analysis) | Breast cancer cells | Human | Cancer | University of California, Davis | LC-MS |
| ST000075 | AN000119 | Combined Metabolomics and Lipidomics of Type 1 Diabetes (QTOF) | Blood | Mouse | Diabetes | University of California, Davis | LC-MS |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS |
